Redox proteomics - PubMed (original) (raw)
Editorial
Redox proteomics
D Allan Butterfield et al. Antioxid Redox Signal. 2012.
Abstract
Proteins are major targets of reactive oxygen and nitrogen species (ROS/RNS) and numerous post-translational, reversible or irreversible modifications have been characterized, which may lead to a change in the structure and/or function of the oxidized protein. Redox proteomics is an increasingly emerging branch of proteomics aimed at identifying and quantifying redox-based changes within the proteome both in redox signaling and under oxidative stress conditions. Correlation between protein oxidation and human disease is widely accepted, although elucidating cause and effect remains a challenge. Increasing biomedical data have provided compelling evidences for the involvement of perturbations in redox homeostasis in a large number of pathophysiological conditions and aging. Research toward a better understanding of the molecular mechanisms of a disease together with identification of specific targets of oxidative damage is urgently required. This is the power and potential of redox proteomics. In the last few years, combined proteomics, mass spectrometry (MS), and affinity chemistry-based methodologies have contributed in a significant way to provide a better understanding of protein oxidative modifications occurring in various biological specimens under different physiological and pathological conditions. Hence, this Forum on Redox Proteomics is timely. Original and review articles are presented on various subjects ranging from redox proteomics studies of oxidatively modified brain proteins in Alzheimer disease and animal models of Alzheimer and Parkinson disease, to potential new biomarker discovery paradigm for human disease, to chronic kidney disease, to protein nitration in aging and age-related neurodegenerative disorders, electrophile-responsive proteomes of special relevance to diseases involving mitochondrial alterations, to cardiovascular physiology and pathology.
Similar articles
- Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to Disease.
Butterfield DA, Perluigi M. Butterfield DA, et al. Antioxid Redox Signal. 2017 Mar 1;26(7):277-279. doi: 10.1089/ars.2016.6919. Epub 2017 Jan 6. Antioxid Redox Signal. 2017. PMID: 27835924 Free PMC article. - Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R. Butterfield DA, et al. Antioxid Redox Signal. 2012 Dec 1;17(11):1610-55. doi: 10.1089/ars.2011.4109. Epub 2012 Jan 18. Antioxid Redox Signal. 2012. PMID: 22115501 Free PMC article. Review. - Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants.
Rinalducci S, Murgiano L, Zolla L. Rinalducci S, et al. J Exp Bot. 2008;59(14):3781-801. doi: 10.1093/jxb/ern252. J Exp Bot. 2008. PMID: 18977746 Review. - Mass spectrometry and redox proteomics: applications in disease.
Butterfield DA, Gu L, Di Domenico F, Robinson RA. Butterfield DA, et al. Mass Spectrom Rev. 2014 Jul-Aug;33(4):277-301. doi: 10.1002/mas.21374. Epub 2013 Sep 30. Mass Spectrom Rev. 2014. PMID: 24930952 Review. - Redox proteomics: from bench to bedside.
Ckless K. Ckless K. Adv Exp Med Biol. 2014;806:301-17. doi: 10.1007/978-3-319-06068-2_13. Adv Exp Med Biol. 2014. PMID: 24952188 Review.
Cited by
- Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification.
Cadenas-Garrido P, Schonvandt-Alarcos A, Herrera-Quintana L, Vázquez-Lorente H, Santamaría-Quiles A, Ruiz de Francisco J, Moya-Escudero M, Martín-Oliva D, Martín-Guerrero SM, Rodríguez-Santana C, Aragón-Vela J, Plaza-Diaz J. Cadenas-Garrido P, et al. Antioxidants (Basel). 2024 Jan 20;13(1):127. doi: 10.3390/antiox13010127. Antioxidants (Basel). 2024. PMID: 38275652 Free PMC article. Review. - Antibacterial and antibiofilm effects of Pseudomonas aeruginosa derived outer membrane vesicles against Streptococcus mutans.
Gurunathan S, Thangaraj P, Das J, Kim JH. Gurunathan S, et al. Heliyon. 2023 Nov 26;9(12):e22606. doi: 10.1016/j.heliyon.2023.e22606. eCollection 2023 Dec. Heliyon. 2023. PMID: 38125454 Free PMC article. - Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.
Perluigi M, Di Domenico F, Butterfield DA. Perluigi M, et al. Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Review. - Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease.
Ganguly U, Kaur U, Chakrabarti SS, Sharma P, Agrawal BK, Saso L, Chakrabarti S. Ganguly U, et al. Oxid Med Cell Longev. 2021 Apr 16;2021:7086512. doi: 10.1155/2021/7086512. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33953837 Free PMC article. Review. - Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond.
Daiber A, Hahad O, Andreadou I, Steven S, Daub S, Münzel T. Daiber A, et al. Redox Biol. 2021 Jun;42:101875. doi: 10.1016/j.redox.2021.101875. Epub 2021 Jan 23. Redox Biol. 2021. PMID: 33541847 Free PMC article. Review.
References
- Butterfield DA. Poon HF. St. Clair D. Keller JN. Pierce WM. Klein JB. Markesbery WR. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis. 2006;22:223–232. - PubMed
- Butterfield DA. Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis. 2007;12:61–72. - PubMed
- Dalle-Donne I. Rossi R. Colombo G. Giustarini D. Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci. 2009;34:85–96. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical